Sugi Predict

Sugi Predict / Compounds / SCHEMBL30567754

SCHEMBL30567754

SCHEMBL30567754

CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CO)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O

nearest known ligand 0.65

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ C5AR1 P21730 1/20 0.65
▸ CALCR P30988 5/20 0.63
▸ F2 P00734 4/20 0.61
▸ NPY2R P49146 8/20 0.60
▸ NPY4R P50391 8/20 0.60
▸ NPY5R Q15761 8/20 0.60
▸ NPY1R P25929 6/20 0.60
▸ RAMP1 O60894 1/20 0.58
▸ RAMP2 O60895 1/20 0.58
▸ RAMP3 O60896 1/20 0.58
▸ CALCRL Q16602 1/20 0.58
▸ CRHR1 P34998 1/20 0.58
▸ CRHR2 Q13324 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31182738 0.93 CALCR (0.67) C5AR1CALCRF2NPY2RNPY4R
SCHEMBL31182622 0.90 CALCR (0.72) CALCRF2NPY2RNPY4RNPY5R
SCHEMBL30423662 0.90 CALCR (0.62) C5AR1CALCRF2CRHR1CRHR2
SCHEMBL31462344 0.90 CALCR (0.65) C5AR1CALCRF2NPY2RNPY4R
SCHEMBL29767745 0.90 CALCR (0.63) C5AR1CALCRF2NPY2RNPY1R
SCHEMBL30008485 0.89 CALCR (0.62) C5AR1CALCRF2NPY2RNPY1R
SCHEMBL30495758 0.89 CALCR (0.72) CALCRF2NPY2RNPY4RNPY5R
SCHEMBL30973953 0.89 C5AR1 (0.63) C5AR1CALCRNPY2RNPY4RNPY5R
SCHEMBL29767747 0.89 CALCR (0.64) C5AR1CALCRF2NPY2RNPY1R
SCHEMBL30844080 0.89 CALCR (0.67) CALCRF2CRHR1CRHR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240277841-A2 HUMAN CHIMERIC ANTIGEN RECEPTOR NEUTROPHILS, COMPOSITIONS, KITS AND METHODS OF USE NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2024-08-22 — — US disclosed
US-20240024473-A1 HUMAN CHIMERIC ANTIGEN RECEPTOR NEUTROPHILS, COMPOSITIONS, KITS AND METHODS OF USE PURDUE RESEARCH FOUNDATION (US) 2024-01-25 — — US disclosed
CN-116601290-A Human chimeric antigen receptor neutrophils, compositions, kits and methods of use 普渡研究基金会 2023-08-15 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240277841-A2 HUMAN CHIMERIC ANTIGEN RECEPTOR NEUTROPHILS, COMPOSITIONS, KITS AND METHODS OF USE PBK, KIT, MYD88 C5AR1 59/4885CALCR 889/4885F2 3626/4885
US-20240024473-A1 HUMAN CHIMERIC ANTIGEN RECEPTOR NEUTROPHILS, COMPOSITIONS, KITS AND METHODS OF USE PBK, KIT, MYD88 C5AR1 59/4885CALCR 889/4885F2 3626/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback